Well being Information Roundup: China lacked a ‘zero COVID’ exit plan. Its persons are paying the worth; Omicron subvariant XBB jumps to 18% of U.S. COVID instances – CDC and
Following is a abstract of present well being information briefs. U.S. FDA approves Acer Therapeutics' genetic dysfunction drug The U.S....